Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy
Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients. […]
» Read moreA recent study provides insights on the COVID-19 pandemic’s effects on employment, anxiety, and financial distress among women who have […] Lung cancer is a major global cause of mortality, reportedly accounting for 1.7 million deaths each year. The most common […] Using a widely known field of mathematics designed mainly to study how digital and other forms of information are measured, […] Cancer has been the focus much research in the biomedical fields. Today, with research methods advancing rapidly and the base […] People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune […] Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with a high fatality rate. Currently, chemotherapy is the […] The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major […] Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death […] Cancer is one of the top causes of death worldwide. The cancer burden is related not only to genetic predisposition, […]
Women with gynecologic cancer and low income report increased financial stress and anxiety during COVID-19 pandemic
Preoperative sarcopenia and exercise intolerance predict outcomes following lung cancer surgery
Field of mathematics reveals a potential gene that causes acute lymphoblastic leukemia
Unlocking new avenues for curing cancer: Cell receptor neuropilin-1 could hold the key
Recovered COVID-19 patients may need only a single vaccine dose, suggests study
CityU researchers identify super-enhancers that stimulate the activity of breast cancer genes
Diabetes drug shows potential in fighting cancer
Adverse Reactions to Immunotherapy Can Appear After a Year
Mapping the paradigm shift of China’s cancer burden for designing prevention strategies
